Home > Pharmaceuticals > Products & Services > TARCEVA

Products & Services

TARCEVAź

TARCEVA contains the active ingredient erlotinib.

TARCEVA is used for the treatment of advanced or metastatic (spreading) non-small cell lung cancer (NSCLC) after previous treatment with chemotherapy.

TARCEVA belongs to a group of medicines called anti-neoplastic agents which are used to treat cancer.

TARCEVA prevents the activity of a protein called epidermal growth factor receptor. This protein is known to be involved in the growth and spread of cancer cells.

Your doctor, however, may have prescribed TARCEVA for another purpose.

This medicine is available only with a doctor's prescription.


Back
© 2007 Roche Pakistan Limited. Legal Statement - Privacy Policy.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.